Source comparison
CJC-1295 No DAC Dosage Comparison: Research Protocol Variables
Before selecting a dosing protocol, researchers must understand how administration frequency, timing, and combination strategies affect growth hormone dynamics and IGF-1 response. This comparison examines three standard frameworks used in published body compos
This comparison does not assign a generated winner or score.
- Before selecting a dosing protocol, researchers must understand how administration frequency, timing, and combination strategies affect growth hormone dynamics and IGF-1 response. This comparison examines three standard frameworks used in published body composition and metabolic research.
- Single Daily
- 200–300mcg
- Once per day
- Before sleep (within 30 min of bedtime)
- Peak at 8–12hrs, sustained 15–25% elevation for 24–36hrs
- Sleep quality studies, nocturnal GH pulse amplification, minimal-intervention protocols
- Best for researchers prioritizing compliance and targeting nocturnal pulse. Produces measurable IGF-1 elevation with single daily administration but misses morning and post-exercise pulse windows
- Twice Daily
- 100mcg
- Two times per day
- Upon waking + before sleep (12–14hr interval)
- Biphasic elevation, sustained 20–30% above baseline with stable trough
- Body composition research, sustained anabolic signaling, balanced pulsatility
- Optimal balance between physiological replication and practical feasibility. Hits both major endogenous pulse windows without requiring mid-day dosing
- Three Times Daily
- Three times per day
- Upon waking + post-workout (or mid-afternoon) + before sleep
- Closest to endogenous pulse pattern, stable 25–35% IGF-1 elevation, minimal trough periods
- Advanced body recomposition, athletic recovery research, metabolic optimization studies
- Maximum pulse replication with greatest IGF-1 stability. Requires strict timing compliance but produces most consistent anabolic environment and highest cumulative GH exposure
- Combination with GHRP
- 75–100mcg CJC + 100mcg GHRP
- 1–3 times per day depending on GHRP used
- Aligned with natural pulse windows (same as above frameworks)
- Synergistic release produces 3–5× higher peak GH than either compound alone, IGF-1 elevation 30–45% above baseline
- Dual-pathway activation research, maximum GH release studies, accelerated outcomes
- Most powerful protocol for GH release amplitude. The GHRH + ghrelin receptor dual activation produces supraphysiological peaks that single-pathway stimulation cannot achieve, requires lower CJC-1295 no DAC dosage due to synergy